Clinical Trial

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To demonstrate the non-inferiority of Ilaprazole 10 mg to the active control in prevention of NSAIDs-associated peptic ulcer, as assessed by the proportion of subjects with peptic ulcer by Week 24
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-27.
Status change: Not Yet Recruiting → Recruiting 2025-05-25
Trial Details
NCT Number NCT06284876
Lead Sponsor Il-Yang Pharm. Co., Ltd.
Conditions Peptic Ulcer
Enrollment 416 participants
Start Date 2024-07-23
Primary Completion 2026-08-30 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-05-30